David Rex Hunter, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 640 Court St, West Branch, MI 48661 Phone: 989-345-8120 |
News Archive
VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted against the following question: "Based on the current available data, do you believe the overall benefit-risk assessment of PHEN/TPM (QNEXA) is favorable to support its approval for the treatment of obesity in individuals with a BMI > 30 kg/m2 or > 27 kg/m2 with weight-related co-morbidities?" The three co-morbidities included hypertension, diabetes and dyslipidemia.
A study from the Thoracic Oncology Research Group, Division of Pulmonary Critical Care, Medical University of South Carolina aimed to examine the adherence to annual low-dose computed tomography screening after baselines LDCT within the Veteran Health Administration Lung Cancer Screening Demonstration Project.
The ultimate value and success of the new "MyPyramid" Food Guidance System graphic will be measured by whether it can serve as an effective tool to help people eat according to the 2005 Dietary Guidelines for Americans. Time will tell if MyPyramid will convey to consumers the vital nutritional messages of balance, variety, moderation and adequacy.
In early 2019, Tom Wolf posted a thank-you on Twitter to the cop who had arrested him the previous spring, when he was homeless and strung out in a doorway with 103 tiny bindles of heroin and cocaine in a plastic baggie at his feet.
Vermillion, Inc., a molecular diagnostics company, today announced that the U.S. Patent Office (USPTO) has issued patent number 7,605,003 titled "Use of biomarkers for detecting ovarian cancer" to the Company for the discovery of biomarkers for ovarian cancer.
› Verified 2 days ago